SBIR/STTR Research Award

Effects of Chondroitinase and Training in Acute SCI

Award identifier b574978f27d66270b20ad6822f84bef909e6fe24286d896652db79be6bc12a3fAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$156,491

Program and phase

SBIR · Phase I

Award year

2005

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Acorda Therapeutics, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
R5D3FUPFFPK4
Solicitation number
PHS2005-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Spinal cord injury (SCI) inflicts trauma to the cells and tissues of the central nervous system and typically results in debilitating loss of function below the level of injury, for which no effective treatment exists. Chondroitin Sulfate Proteoglycans (CSPGs) an important component of the glial scar. The majority are potently inhibitory for axonal growth and hence contribute to the failure of these axons to regenerate and form functional synapses following SCI. Chondroitinase, a bacterial enzyme that catalyzes the breakdown of CSPGs, has been shown to improve motor and sensory function and enhance regeneration following SCI in various studies. It also re-establishes a period of plasticity in the ocular dominance columns when injected in the parenchyma of the visual cortex. Physical therapy in the form of various exercise paradigms, such as treadmill training or swimming has shown to improve functional recovery in both clinical and experimental settings. These training paradigms have been accompanied by increases in the levels of expression of neurotrophins such as brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT-3) and neurotrophin 4 (NT-4). There is also evidence in the literature supporting instrumental learning and plasticity in the spinal cord. Based on recent evidence comparing various training paradigms that involve either rhythmicity and/or load on recovery of sensory function, we wanted to examine the effects of acute treatment of Chondroitinase combined with training in the forceps compression model of SCI. Results of these experiments will help us understand the effects of different types of training alone and in combination with Chondroitinase on various functional and histological outcome measures. The ultimate goal is to develop Chondroitinase as a potential therapeutic for the treatment of SCI and examine its potential role in the population of patients undergoing various types of physical therapy on a routine basis.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

10 SBIR/STTR records share this UEI (1996–2005). Reported award amounts total $2,216,009. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.